Karyopharm Therapeutics (KPTI) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-5.71
-4.47
-3.23
-1.99

Details

Expected EPS
-1.994286
Actual EPS
-5.71
Surprise EPS
-3.72
Surprise Percent
-186.32%

Description

⁨Karyopharm Therapeutics⁩ (⁦KPTI⁩) has reported earnings of ⁦-5.71⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts